You are now leaving the Kedrion Corporate site. The information available in your chosen website may not be in compliance with EU legislation regulating the advertising of medicinal products for human use, nor do the opinions expressed necessarily reflect the Company’s positions or are endorsed by it. In addition as per local health authority Regulations, some of our products are not approved for sales, marketing or distribution in all countries.
NO
YES
  1. CORPORATE - 07-04-2020

    Coronavirus, from Plasma an anti Covid-19 treatment

    Kedrion’s commitment to find a treatment from convalescent patient plasma

    read more 
  2. CORPORATE - 20-03-2020

    Letter to patient associations and scientific organizations

    Communication from Paolo Marcucci, Chairman & CEO of Kedrion

    read more 
  3. CORPORATE - 16-10-2019

    FSI SGR enters Kedrion share capital

    The company continues with its growth and development strategy

    read more 

Pages

For more information please contact: pressoffice@kedrion.com